Literature DB >> 17020948

Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing.

Iñigo Narvaiza1, Oscar Aparicio, María Vera, Nerea Razquin, Sergia Bortolanza, Jesús Prieto, Puri Fortes.   

Abstract

RNA interference with viral vectors that express short hairpin RNAs (shRNAs) has emerged as a powerful tool for functional genomics and therapeutic purposes. However, little is known about shRNA in vivo processing, accumulation, functional kinetics, and side effects related to shRNA saturation of the cellular gene silencing machinery. Therefore, we constructed first-generation recombinant adenoviruses encoding different shRNAs against murine ATP-binding cassette multidrug resistance protein 2 (Abcc2), which is involved in liver transport of bilirubin to bile, and analyzed Abcc2 silencing kinetics. C57/BL6 mice injected with these viruses showed significant impairment of Abcc2 function for up to 3 weeks, as reflected by increased serum bilirubin levels. The lack of Abcc2 function correlated with a specific reduction of Abcc2 mRNA and with high levels of processed shRNAs targeting Abcc2. Inhibition was lost at longer times postinfection, correlating with a decrease in the accumulation of processed shRNAs. This finding suggests that a minimal amount of processed shRNAs is required for efficient silencing in vivo. This system was also used to evaluate the effect of shRNA expression on the saturation of silencing factors. Saturation of the cellular silencing processing machinery alters the accumulation and functionality of endogenous microRNAs (miRNAs) and pre-miRNAs. However, expression of functional exogenous shRNAs did not change the levels of endogenous miRNAs or their precursors. In summary, this work shows that adenoviral vectors can deliver sufficient shRNAs to mediate inhibition of gene expression without saturating the silencing machinery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17020948      PMCID: PMC1676304          DOI: 10.1128/JVI.01205-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome.

Authors:  V Keitel; J Kartenbeck; A T Nies; H Spring; M Brom; D Keppler
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

Review 2.  Perspective: machines for RNAi.

Authors:  Yukihide Tomari; Phillip D Zamore
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

Review 3.  Small RNAs: classification, biogenesis, and function.

Authors:  V Narry Kim
Journal:  Mol Cells       Date:  2005-02-28       Impact factor: 5.034

4.  Cancer genomics: small RNAs with big impacts.

Authors:  Paul S Meltzer
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 5.  MicroRNAs: a developing story.

Authors:  Amy E Pasquinelli; Shaun Hunter; John Bracht
Journal:  Curr Opin Genet Dev       Date:  2005-04       Impact factor: 5.578

6.  Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs.

Authors:  Rui Yi; Brian P Doehle; Yi Qin; Ian G Macara; Bryan R Cullen
Journal:  RNA       Date:  2004-12-21       Impact factor: 4.942

Review 7.  Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.

Authors:  J König; A T Nies; Y Cui; I Leier; D Keppler
Journal:  Biochim Biophys Acta       Date:  1999-12-06

8.  Identification of microRNAs of the herpesvirus family.

Authors:  Sébastien Pfeffer; Alain Sewer; Mariana Lagos-Quintana; Robert Sheridan; Chris Sander; Friedrich A Grässer; Linda F van Dyk; C Kiong Ho; Stewart Shuman; Minchen Chien; James J Russo; Jingyue Ju; Glenn Randall; Brett D Lindenbach; Charles M Rice; Viviana Simon; David D Ho; Mihaela Zavolan; Thomas Tuschl
Journal:  Nat Methods       Date:  2005-02-16       Impact factor: 28.547

9.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

10.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

View more
  27 in total

1.  Robust hepatic gene silencing for functional studies using helper-dependent adenoviral vectors.

Authors:  Rafaela Ruiz; Scott R Witting; Romil Saxena; Núria Morral
Journal:  Hum Gene Ther       Date:  2009-01       Impact factor: 5.695

Review 2.  Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.

Authors:  Elena Herrera-Carrillo; Ying Poi Liu; Ben Berkhout
Journal:  Hum Gene Ther Methods       Date:  2017-08       Impact factor: 2.396

Review 3.  RNA viruses and the host microRNA machinery.

Authors:  Benjamin R tenOever
Journal:  Nat Rev Microbiol       Date:  2013-03       Impact factor: 60.633

4.  Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities.

Authors:  Yannick Bulliard; Iñigo Narvaiza; Alessandro Bertero; Shyam Peddi; Ute F Röhrig; Millán Ortiz; Vincent Zoete; Nataly Castro-Díaz; Priscilla Turelli; Amalio Telenti; Olivier Michielin; Matthew D Weitzman; Didier Trono
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

Review 5.  Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.

Authors:  Jayshree Mishra; Joseph Drummond; Sohel H Quazi; Satya Sridhar Karanki; J J Shaw; Ben Chen; Narendra Kumar
Journal:  Crit Rev Oncol Hematol       Date:  2012-10-23       Impact factor: 6.312

6.  Recombinant Adeno-Associated Virus-Mediated microRNA Delivery into the Postnatal Mouse Brain Reveals a Role for miR-134 in Dendritogenesis in Vivo.

Authors:  Mette Christensen; Lars A Larsen; Sakari Kauppinen; Gerhard Schratt
Journal:  Front Neural Circuits       Date:  2010-01-12       Impact factor: 3.492

7.  Combination of RNA interference and U1 inhibition leads to increased inhibition of gene expression.

Authors:  X Abad; N Razquin; A Abad; P Fortes
Journal:  Nucleic Acids Res       Date:  2010-04-28       Impact factor: 16.971

8.  Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway.

Authors:  Matthias John; Rainer Constien; Akin Akinc; Michael Goldberg; Young-Ah Moon; Martina Spranger; Philipp Hadwiger; Jürgen Soutschek; Hans-Peter Vornlocher; Muthiah Manoharan; Markus Stoffel; Robert Langer; Daniel G Anderson; Jay D Horton; Victor Koteliansky; David Bumcrot
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

9.  Evaluation of monocytes as carriers for armed oncolytic adenoviruses in murine and Syrian hamster models of cancer.

Authors:  Maria Bunuales; Eva Garcia-Aragoncillo; Raquel Casado; José Ignacio Quetglas; Sandra Hervas-Stubbs; Sergia Bortolanza; Carolina Benavides-Vallve; Carlos Ortiz-de-Solorzano; Jesus Prieto; Ruben Hernandez-Alcoceba
Journal:  Hum Gene Ther       Date:  2012-10-26       Impact factor: 5.695

10.  Adenovirus VA RNA-derived miRNAs target cellular genes involved in cell growth, gene expression and DNA repair.

Authors:  Oscar Aparicio; Elena Carnero; Xabier Abad; Nerea Razquin; Elizabeth Guruceaga; Victor Segura; Puri Fortes
Journal:  Nucleic Acids Res       Date:  2009-11-19       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.